Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | PPARG | P37231 | 7/20 | 0.56 |
| ▸ | PPARA | Q07869 | 7/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | POLA1 | P09884 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.53 |
| ▸ | BACE1 | P56817 | 1/20 | 0.53 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.51 |
| ▸ | PPARD | Q03181 | 5/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL370068 | 1.00 | TRPA1 (0.66) | TRPA1KDM4EPPARGPPARAALOX12 | |
| SCHEMBL18730280 | 0.98 | TRPA1 (0.63) | TRPA1KDM4EPPARGPPARAALOX12 | |
| SCHEMBL18730282 | 0.98 | TRPA1 (0.63) | TRPA1KDM4EPPARGPPARAALOX12 | |
| SCHEMBL2538214 | 0.98 | TRPA1 (0.63) | TRPA1KDM4EPPARGPPARAALOX12 | |
| SCHEMBL2540152 | 0.98 | TRPA1 (0.63) | TRPA1KDM4EPPARGPPARAALOX12 | |
| SCHEMBL16040410 | 0.98 | TRPA1 (0.63) | TRPA1KDM4EPPARGPPARAALOX12 | |
| SCHEMBL16040409 | 0.98 | TRPA1 (0.63) | TRPA1KDM4EPPARGPPARAALOX12 | |
| SCHEMBL2135456 | 0.98 | TRPA1 (0.63) | TRPA1KDM4EPPARGPPARAALOX12 | |
| SCHEMBL887711 | 0.98 | TRPA1 (0.63) | TRPA1KDM4EPPARGPPARAALOX12 | |
| SCHEMBL28149740 | 0.98 | TRPA1 (0.63) | TRPA1KDM4EPPARGPPARAALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260060248-A1 | POWDERY PLANT ACTIVATOR | IBIDEN CO., LTD. (JP) | 2026-03-05 | — | — | US | claimed |
| US-12543732-B2 | Powdery plant activator | IBIDEN CO., LTD. (JP) | 2026-02-10 | — | — | US | claimed |
| WO-2025094894-A1 | PLANT ACTIVATOR | イビデン株式会社 | 2025-05-08 | — | — | WO | claimed |
| US-20250027938-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-01-23 | — | — | US | claimed |
| CN-118870973-A | Penetration enhancer | 揖斐电株式会社 | 2024-10-29 | — | — | CN | claimed |
| WO-2024162111-A1 | PENETRATION ENHANCER | イビデン株式会社 | 2024-08-08 | — | — | WO | claimed |
| US-20240251791-A1 | POWDERY PLANT ACTIVATOR | IBIDEN CO., LTD. (JP) | 2024-08-01 | — | — | US | claimed |
| EP-4370919-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | Imperial College Innovations Limited (GB) | 2024-05-22 | — | — | EP | claimed |
| EP-4349168-A1 | POWDERY PLANT ACTIVATOR | IBIDEN CO., LTD. (JP) | 2024-04-10 | — | — | EP | claimed |
| CN-117412672-A | Powdered plant activator | 揖斐电株式会社 | 2024-01-16 | — | — | CN | claimed |
| WO-2023285832-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-01-19 | — | — | WO | claimed |
| WO-2022255419-A1 | POWDERY PLANT ACTIVATOR | イビデン株式会社 | 2022-12-08 | — | — | WO | claimed |
| EP-3362053-A1 | TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS WITH DELAYED-RELEASE 6-MERCAPTOPURINE | Teva Pharmaceutical Industries Ltd. (IL) | 2018-08-22 | — | — | EP | claimed |
| WO-2017066619-A1 | TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS WITH DELAYED-RELEASE 6-MERCAPTOPURINE | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2017-04-20 | — | — | WO | claimed |
| EP-0437694-B1 | Use of a hydroxyoctadécadiene acid, its keto-oxydized acid and their derivatives in the treatment of estrogen-dependent diseases, and pharmaceutical compositions thereof | Boots Pharma GmbH (DE) | 1993-06-16 | — | — | EP | claimed |
| US-20260060248-A1 | POWDERY PLANT ACTIVATOR | IBIDEN CO., LTD. (JP) | 2026-03-05 | — | — | US | disclosed |
| US-12543732-B2 | Powdery plant activator | IBIDEN CO., LTD. (JP) | 2026-02-10 | — | — | US | disclosed |
| WO-2011140093-A2 | DETECTION AND MONITORING OF NONALCOHOLIC FATTY LIVER DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2011-11-10 | — | — | WO | disclosed |
| WO-2010123221-A9 | COMPOSITION FOR PREVENTING AND IMPROVING THE SYMPTOMS OF MENOPAUSE, CONTAINING GLYCEOLLINS AS AN ACTIVE INGREDIENT | 경북대학교 산학협력단 (KR) | 2010-12-16 | — | — | WO | disclosed |
| WO-2010123221-A2 | COMPOSITION FOR PREVENTING AND IMPROVING THE SYMPTOMS OF MENOPAUSE, CONTAINING GLYCEOLLINS AS AN ACTIVE INGREDIENT | 경북대학교 산학협력단 (KR) | 2010-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12543732-B2 | Powdery plant activator | PER2, SCD, FADS2 | TRPA1 219/4885KDM4E 1644/4885PPARG 112/4885 |
| US-20260060248-A1 | POWDERY PLANT ACTIVATOR | ALOX5, ALOX15, FADS2 | TRPA1 193/4885KDM4E 2950/4885PPARG 222/4885 |
| US-20240251791-A1 | POWDERY PLANT ACTIVATOR | BROX, GET3, OSBPL8 | TRPA1 828/4885KDM4E 2884/4885PPARG 82/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.